Yuan Guoyong pointed out that Kexing vaccine has less side effects; although Fubitai vaccine has greater side effects, it triggers stronger neutralizing antibodies and lymphocyte-directed immunity. He considered that he did not have cardiovascular, cerebrovascular, or other long-term diseases, and he had to see patients, “coronavirus,” and even inspect the outbreak site, so he chose to be vaccinated with the more protective Fubitai vaccine.
Yuan Guoyong has said in the past that he would be vaccinated with the nasal spray new crown vaccine developed by the University of Hong Kong. He today said that because the vaccine of the University of Hong Kong could not be shipped from the Mainland to Hong Kong in a short time, and he is 64 years old this year, he is not eligible to participate in the first clinical study of the vaccine of the University of Hong Kong. , So choose to vaccinate the vaccine that has arrived in Hong Kong. He said that the currently available new crown vaccine has been observed for one year since the first phase of clinical research and no serious adverse reactions have been seen. He believes that there has been enough time to prove that the vaccine is safe and effective. When it comes to the epidemic,” he hopes to personally vaccinate “as an example,” and appeals to the public to “don’t get an injection because they are afraid of pain,” and they should get the new crown vaccine as soon as possible.
New crown vaccine related reports:
–
